BME:BME

BlackRock Health Sciences Trust Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume138,901 shs
Average Volume148,662 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

BlackRock Health Sciences Trust (BME:BME) Vs. DWS, GLJ, MLP, DBAN, ACKB, and BKT

Should you be buying BME stock or one of its competitors? Companies in the industry of "asset management" are considered alternatives and competitors to BlackRock Health Sciences Trust, including DWS Group GmbH & Co. KGaA (DWS), Grenke (GLJ), MLP (MLP), Deutsche Beteiligungs (DBAN), Ackermans & Van Haaren (ACKB), and BlackRock Income Trust (BKT).

BlackRock Health Sciences Trust (BME:BME) and DWS Group GmbH & Co. KGaA (ETR:DWS) are both financial services companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends and institutional ownership.

Earnings and Valuation

This table compares BlackRock Health Sciences Trust and DWS Group GmbH & Co. KGaA's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BlackRock Health Sciences TrustN/AN/AN/AN/AN/A
DWS Group GmbH & Co. KGaA$3.35 billion2.31$556 million€2.7813.90

DWS Group GmbH & Co. KGaA has higher revenue and earnings than BlackRock Health Sciences Trust.

Profitability

This table compares BlackRock Health Sciences Trust and DWS Group GmbH & Co. KGaA's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BlackRock Health Sciences TrustN/AN/AN/A
DWS Group GmbH & Co. KGaAN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for BlackRock Health Sciences Trust and DWS Group GmbH & Co. KGaA, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BlackRock Health Sciences Trust0000N/A
DWS Group GmbH & Co. KGaA011102.92

DWS Group GmbH & Co. KGaA has a consensus target price of €39.71, indicating a potential upside of 2.77%.

Summary

DWS Group GmbH & Co. KGaA beats BlackRock Health Sciences Trust on 2 of the 2 factors compared between the two stocks.

Grenke (ETR:GLJ) and BlackRock Health Sciences Trust (BME:BME) are both financial services companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Profitability

This table compares Grenke and BlackRock Health Sciences Trust's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
GrenkeN/AN/AN/A
BlackRock Health Sciences TrustN/AN/AN/A

Earnings and Valuation

This table compares Grenke and BlackRock Health Sciences Trust's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Grenke$537.48 million2.89$86.81 million€1.8717.88
BlackRock Health Sciences TrustN/AN/AN/AN/AN/A

Grenke has higher revenue and earnings than BlackRock Health Sciences Trust.

Analyst Recommendations

This is a summary of current recommendations and price targets for Grenke and BlackRock Health Sciences Trust, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Grenke12402.43
BlackRock Health Sciences Trust0000N/A

Grenke currently has a consensus price target of €67.14, indicating a potential upside of 101.09%.

Summary

Grenke beats BlackRock Health Sciences Trust on 2 of the 2 factors compared between the two stocks.

BlackRock Health Sciences Trust (BME:BME) and MLP (ETR:MLP) are both financial services companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

Analyst Ratings

This is a summary of recent recommendations and price targets for BlackRock Health Sciences Trust and MLP, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BlackRock Health Sciences Trust0000N/A
MLP01102.50

MLP has a consensus price target of €7.45, suggesting a potential upside of 6.58%.

Earnings & Valuation

This table compares BlackRock Health Sciences Trust and MLP's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BlackRock Health Sciences TrustN/AN/AN/AN/AN/A
MLP$767.30 million0.99$43.50 million€0.4017.48

MLP has higher revenue and earnings than BlackRock Health Sciences Trust.

Profitability

This table compares BlackRock Health Sciences Trust and MLP's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BlackRock Health Sciences TrustN/AN/AN/A
MLPN/AN/AN/A

Summary

MLP beats BlackRock Health Sciences Trust on 2 of the 2 factors compared between the two stocks.

Deutsche Beteiligungs (ETR:DBAN) and BlackRock Health Sciences Trust (BME:BME) are both financial services companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk.

Valuation and Earnings

This table compares Deutsche Beteiligungs and BlackRock Health Sciences Trust's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Deutsche Beteiligungs$39.80 million13.19$8.88 million€0.5959.15
BlackRock Health Sciences TrustN/AN/AN/AN/AN/A

Deutsche Beteiligungs has higher revenue and earnings than BlackRock Health Sciences Trust.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Deutsche Beteiligungs and BlackRock Health Sciences Trust, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Deutsche Beteiligungs00503.00
BlackRock Health Sciences Trust0000N/A

Deutsche Beteiligungs presently has a consensus price target of €45.44, suggesting a potential upside of 30.20%.

Profitability

This table compares Deutsche Beteiligungs and BlackRock Health Sciences Trust's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Deutsche BeteiligungsN/AN/AN/A
BlackRock Health Sciences TrustN/AN/AN/A

Summary

Deutsche Beteiligungs beats BlackRock Health Sciences Trust on 2 of the 2 factors compared between the two stocks.

Ackermans & Van Haaren (EBR:ACKB) and BlackRock Health Sciences Trust (BME:BME) are both financial services companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, risk, institutional ownership, earnings and analyst recommendations.

Valuation & Earnings

This table compares Ackermans & Van Haaren and BlackRock Health Sciences Trust's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ackermans & Van HaarenN/AN/AN/AN/AN/A
BlackRock Health Sciences TrustN/AN/AN/AN/AN/A

Profitability

This table compares Ackermans & Van Haaren and BlackRock Health Sciences Trust's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ackermans & Van HaarenN/AN/AN/A
BlackRock Health Sciences TrustN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and target prices for Ackermans & Van Haaren and BlackRock Health Sciences Trust, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ackermans & Van Haaren0000N/A
BlackRock Health Sciences Trust0000N/A

BlackRock Income Trust (BME:BKT) and BlackRock Health Sciences Trust (BME:BME) are both financial services companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership and dividends.

Valuation & Earnings

This table compares BlackRock Income Trust and BlackRock Health Sciences Trust's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BlackRock Income TrustN/AN/AN/AN/AN/A
BlackRock Health Sciences TrustN/AN/AN/AN/AN/A

Profitability

This table compares BlackRock Income Trust and BlackRock Health Sciences Trust's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BlackRock Income TrustN/AN/AN/A
BlackRock Health Sciences TrustN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for BlackRock Income Trust and BlackRock Health Sciences Trust, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BlackRock Income Trust0000N/A
BlackRock Health Sciences Trust0000N/A


BlackRock Health Sciences Trust Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
DWS Group GmbH & Co. KGaA logo
DWS
DWS Group GmbH & Co. KGaA
1.9$38.64flat$7.73 billion$3.35 billion13.90Analyst Report
High Trading Volume
News Coverage
Grenke logo
GLJ
Grenke
1.8$33.39flat$1.55 billion$537.48 million17.88High Trading Volume
MLP logo
MLP
MLP
1.3$6.99flat$760.23 million$767.30 million17.48
Deutsche Beteiligungs logo
DBAN
Deutsche Beteiligungs
1.7$34.90flat$525.04 million$39.80 million59.15Gap Down
ACKB
Ackermans & Van Haaren
0.5N/AN/A$0.00N/A0.00Gap Down
BlackRock Income Trust logo
BKT
BlackRock Income Trust
0.4N/AN/A$0.00N/A0.00
BNY Mellon Strategic Municipal Bond Fund logo
DSM
BNY Mellon Strategic Municipal Bond Fund
0.6N/AN/A$0.00N/A0.00
Groupe Bruxelles Lambert logo
GBLB
Groupe Bruxelles Lambert
0.7N/AN/A$0.00N/A0.00
Rand Capital logo
RAND
Rand Capital
0.4N/AN/A$0.00N/A0.00News Coverage
PYX
Schroders
0.5N/AN/A$0.00N/A0.00High Trading Volume
This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.